| Literature DB >> 23508356 |
Ronishree Naidoo1, Linda Ferreira, Dave K Berger, Alexander A Myburg, Sanushka Naidoo.
Abstract
Two important role players in plant defence response are the phytohormones salicylic acid (SA) and jasmonic acid (JA); both of which have been well described in model species such as Arabidopsis thaliana. Several pathogenesis related (PR) genes have previously been used as indicators of the onset of SA and JA signaling in Arabidopsis. This information is lacking in tree genera such as Eucalyptus. The aim of this study was to characterize the transcriptional response of PR genes (EgrPR2, EgrPR3, EgrPR4, EgrPR5, and EgrLOX) identified in Eucalyptus grandis to SA and methyl jasmonate (MeJA) treatment as well as to qualify them as diagnostic for the two signaling pathways. Using the genome sequence of E. grandis, we identified candidate Eucalyptus orthologs EgrPR2, EgrPR3, EgrPR4, EgrPR5, and EgrLOX based on a co-phylogenetic approach. The expression of these genes was investigated after various doses of SA and MeJA (a derivative of JA) treatment as well as at various time points. The transcript levels of EgrPR2 were decreased in response to high concentrations of MeJA whereas the expression of EgrPR3 and EgrLOX declined as the concentrations of SA treatment increased, suggesting an antagonistic relationship between SA and MeJA. Our results support EgrPR2 as potentially diagnostic for SA and EgrPR3, EgrPR4, and EgrLOX as indicators of MeJA signaling. To further validate the diagnostic potential of the PR genes we challenged E. grandis clones with the fungal necrotrophic pathogen Chrysoporthe austroafricana. The tolerant clone showed high induction of EgrPR2 and decreased transcript abundance of EgrPR4. Pre-treatment of the susceptible genotype with 5 mM SA resulted in lesion lengths comparable to the tolerant genotype after artificial inoculation with C. austroafricana. Thus expression profiling of EgrPR2 and EgrPR4 genes could serve as a useful diagnostic approach to determine which of the two signaling pathways are activated against various pathogens in Eucalyptus.Entities:
Keywords: Eucalyptus; PR genes; PR2; PR4; defence; methyl jasmonate; salicylic acid
Year: 2013 PMID: 23508356 PMCID: PMC3589731 DOI: 10.3389/fpls.2013.00043
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Primer sequence of .
| GCTCTACAACCAGCGCAATATC | GCCAACTGCTATGTACCTGAAC | 214 | |
| CCTGTTGGACGTCAACGCC | GTCGTCGTACTCGAAGATT | 167 | |
| CGGCCGCGAAGTCGTTCCC | AACTATAACTACGGGCAAT | 277 | |
| ATGCCGTGAGCGCATACTG | GCGTGTTGGTCCTGGTGTT | 156 | |
| ATGAACACTTGCTTCCATT | TCCTACCATACGTGAACAA | 165 | |
| TGCGTACCGAGTTGTTGAGG | GTTGCACAGGTGCTCTGGAT | 195 | |
| TGAAGACATGGCAAGGAAGG | GTACCGAAGTTGCTCCGAAT | 190 | |
| TGGAACTGTTGAGTCTGG | TTAGGACCATGAATGAGGAG | 59 | |
Egr, E. grandis.
Predicted gene models and corresponding genomic scaffold regions selected as putative orthologs for the SA and MeJA defence signature genes in .
| AT3G57260 | Scaffold_1: 33791675–33792649 | ||
| AT3G12500 | Scaffold_9: 25149898–25151718 | ||
| AT3G04720 | Scaffold_2: 42319519–42320281 | ||
| AT1G75040 | Scaffold_1: 7623283–7624480 | ||
| AT3G45140 | Scaffold_10: 8809509–8814780 |
No predicted transcript on Phytozome v7.0 for the selected scaffold region.
Figure 1Relative transcript abundance of Putative SA signature defence genes following normalization with EgrARF and EgrFBA. (B) Putative MeJA signature defence genes following normalization with EgrARF and EgrIDH. The y-axis represents the relative transcript abundance ratios expressed in arbitrary units. The x-axis shows the respective concentration range that was applied to the aerial parts of E. grandis plants. Error bars show the standard error of the mean of the biological replicates (n = 3) sampled after 24 hpt. Significance, indicated by *, is relative to the control for each target and was calculated by the Kruskal–Wallis test (p < 0.05).
Figure 2Relative transcript abundance of the putative orthologs for the The y-axis represents the relative expression ratios expressed in arbitrary units. Putative SA signature defence genes (A) were normalized with EguIDH and EgrARF whereas the putative MeJA signature defence genes (B) were normalized with EgrARF and EgrFBA. The x-axis represents the concentration range for the applied inducer. Error bars show the standard error of the mean of the biological replicates (n = 3). Significance, indicated by *, is relative to the control in each graph and was calculated by the Kruskal–Wallis test (p < 0.05).
Figure 3Relative transcript abundance of putative orthologs for SA and MeJA signature defence genes assessed during the time course trial. (A) EgrPR2; (B) EgrPR5; (C) EgrPR3; (D) EgrPR4; (E) EgrLOX2. The y-axis represents the relative expression ratios expressed in arbitrary units. The x-axis represents the time course (h) post-treatment with 5 mM SA (A and B) and 100 μM MeJA (C–E). Samples were normalized with EgrARF and EgrFBA. Error bars are show the standard error of the mean of the biological replicates (n = 3). White boxes represent the control samples whereas the colored boxes represent the treated samples. Significance between the control and treated samples is indicated by * at a specific time point and was calculated by the Kruskal–Wallis test (p < 0.05).
Figure 4Relative transcript abundance of putative orthologs for EgrPR2; (B) EgrPR4. The y-axis represents the relative expression ratios expressed in arbitrary units. The x-axis represents the time points post-inoculation at which the samples were analyzed. Error bars show the standard error of the mean of the biological replicates (n = 3). Samples were normalized to EgrARF and EgrFBA. Light and dark solid boxes represent the TAG5 control and inoculated samples respectively whereas the light and dark striped boxes represent the ZG14 control and inoculated samples respectively. Significance, indicated by *, is relative to the control and was calculated by the Student's t-test (p < 0.05).